Man Group’s C4 Therapeutics CCCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$675K Buy
256,468
+100,370
+64% +$236K ﹤0.01% 1979
2025
Q4
$298K Buy
156,098
+65,820
+73% +$156K ﹤0.01% 2016
2025
Q3
$200K Buy
90,278
+11,791
+15% +$28.3K ﹤0.01% 2109
2025
Q2
$112K Sell
78,487
-7,136
-8% -$10.4K ﹤0.01% 2117
2025
Q1
$137K Buy
+85,623
New +$255K ﹤0.01% 2089
2024
Q2
Sell
-139,900
Closed -$1.14M 2046
2024
Q1
$1.14M Sell
139,900
-19,865
-12% -$154K ﹤0.01% 1495
2023
Q4
$903K Buy
+159,765
New +$364K ﹤0.01% 1484
2023
Q3
Sell
-69,332
Closed -$211K 1673
2023
Q2
$191K Buy
+69,332
New +$223K ﹤0.01% 1827
2023
Q1
Hold
0
1925
2021
Q4
Sell
-6,423
Closed -$287K 1964
2021
Q3
$287K Buy
6,423
+1,000
+18% +$42.8K ﹤0.01% 1661
2021
Q2
$205K Buy
+5,423
New +$194K ﹤0.01% 1795

Other funds holding CCCC